Cilnidipine improves left-ventricular midwall function independently of blood pressure changes in Chinese patients with hypertension

Journal of Cardiovascular Pharmacology

Volumn 49, Issue 1, 2007, Pages 33-38

  Ma, Zhi Yong ^a   Li, Li ^a   Zhong, Xue Zhen ^a   Tan, Hong Wei ^a   Wang, Rong ^a   Wang, Ying ^a   Zhang, Wei ^a   Zhang, Yun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cilnidipine; Essential hypertension; Left ventricular systolic function; Midwall fractional shortening

Indexed keywords

CILNIDIPINE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; SAMPLE SIZE; SHORT COURSE THERAPY; SYSTOLIC BLOOD PRESSURE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CHINA; DIHYDROPYRIDINES; FEMALE; HEART; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 33846587950     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31802bfdee     Document Type: Article

References (25)

1. de Simone G, Devereux RB, Koren MJ, et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996;93:259-265.
2. Verdecchia P, Schillaci G, Reboldi G, et al. Prognostic value of midwall shortening fraction and its relation with left ventricular mass in systemic hypertension. Am J Cardiol. 2001;87:479-482.
3. Lutas EM, Devereux RB, Reis G, et al. Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. Hypertension. 1985;7:979-988.
4. de Simone G, Di Lorenzo L, Costantino G, et al. Supernormal contractility in primary hypertension without left ventricular hypertrophy. Hypertension. 1988;11:457-463.
5. Bing OH, Matsushita S, Fanburg BL, et al. Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circ Res. 1971;28:234-245.
6. Alpert NR, Hamrell BB, Halpern W. Mechanical and biochemical correlates of cardiac hypertrophy. Circ Res. 1974;35:71-82.
7. Shimizu G, Zile MR, Blaustein AS, et al. Left ventricular chamber filling and midwall fiber lengthening in patients with left ventricular hypertrophy: overestimation of fiber velocities by conventional midwall measurements. Circulation. 1985;71:266-272.
8. de Simone G, Devereux RB, Roman MJ, et al. Assessment of left ventricular function by the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444-1451.
9. Greenbaum R, Ho S, Gibson DG. Left ventricular fiber architecture in man. Br Heart J. 1981;45:248-263.
10. Palatini P, Frigo G, Visentin P, et al. Left ventricular contractile performance in the early stage of hypertension in humans. Eur J Appl Physiol. 2001;85:118-124.
11. Devereux RB, de Simone G, Pickering TG, et al. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension. 1998;31:929-936.
12. Schussheim AE, Diamond JA, Jhang JS, et al. Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol. 1998;82:1056-1059.
13. Sakata K, Shirotani M, Yoshida H, et al. Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension. Hypertension. 1999;33:1447-1452.
14. Tan HW, Li L, Zhang W, et al. Effect of cilnidipine on left ventricular function in hypertensive patients as assessed by tissue Doppler Tei index. J Hum Hypertens. 2006;20:618-624.
15. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
16. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
17. Gaasch WH, Zile MR, Hosino PK, et al. Stress shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure overload hypertrophy. Circulation. 1989;79:872-873.
18. Hoshide S, Kario K, Ishikawa J, et al. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure. Hypertens Res. 2005;28:1003-1008.
19. Minami J, Kawano Y, Makino Y, et al. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension. Br J Clin Pharmacol. 2000;50:615-620.
20. de Simone G, Kitzman DW, Palmieri V, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens. 2004;17:828-833.
21. Kozakova M, Ferrannini E, Palombo C. Relation between left ventricular midwall function and coronary vasodilator capacity in arterial hypertension. Hypertension. 2003;42:528-533.
22. Mayet J, Ariff B, Wasan B, et al. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy. Hypertension. 2000;36:755-759.
23. Wachtell K, Palmieri V, Olsen MH, et al. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study. Circulation. 2002;106:227-232.
24. Schussheim AE, Diamond JA, Phillips RA. Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension. Am J Cardiol. 2001;87:61-65.
25. Perlini S, Muiesan ML, Cuspidi C, et al. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation. 2001;103:678-683.